Recent

% | $
Quotes you view appear here for quick access.

Ampio Pharmaceuticals, Inc. Message Board

michaelanderson1942 9 posts  |  Last Activity: Jul 23, 2015 2:45 PM Member since: May 2, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Chart shows buying just beginning to accelerate.

    Millennium Healthcare (MHCC) reported revenues increased over 400% in 2014 to over $8 million

    Total market cap today at $0.01 per share equals less than $2 million.

    At only 10X revenues shares should be selling at $.45 today.

    Aggressive growth - Recently acquired HealthPath and MedX with more to be announced

    Revenues set to explode again in 2015.

    New management is very strong, capable and with strong healthcare relationships.

    Expect big runway of new FDA approved early detection diagnostics for heart and cancer.

    Small investment has potential for very big gains this year.

    Keep MHCC in your portfolio and watch closely for frequent news of big changes

    MHCC 12 month price target - $1.25

    Sentiment: Strong Buy

  • Chart shows turnaround with big increase in volume and buying just beginning to accelerate.

    Millennium Healthcare (MHCC) reported revenues increased over 400% in 2014 to over $8 million

    Total market cap today at $0.01 per share equals less than $2 million.

    At only 10X revenues shares should be selling at $.45 today.

    Revenues set to explode again in 2015.

    New management is very strong, capable and with strong healthcare relationships.

    Expect big runway of new FDA approved early detection diagnostics for heart and cancer.

    Small investment has potential for huge gains this year.

    Keep MHCC in your portfolio and watch closely for frequent news of big changes

    MHCC 12 month price target - $1.25

    Sentiment: Strong Buy

  • Millennium Healthcare (MHCC) reported revenues increased over 400% in 2014 to over $8 million

    Total market cap today at $0.01 per share equals less than $2 million.

    At only 10X revenues shares should be selling at $.45 today.

    Revenues set to explode again in 2015.

    New management is very strong, capable and with strong healthcare relationships.

    Expect big runway of new FDA approved early detection diagnostics for heart and cancer.

    Small investment has potential for huge gains this year.

    Keep MHCC in your portfolio and watch closely for frequent news of big changes

    MHCC 12 month price target - $1.25

    Sentiment: Strong Buy

  • Check him out as this tells the story that BioLargo is for real and is about to surprise very big.

    Sentiment: Strong Buy

  • BioLargo’s (BLGO) AOS filter has been repeatedly validated by researchers at the University of Alberta to decontaminate and disinfect water 100 times better, 10 times faster, and at 1/20th the cost of closest competing technology.

    BioLargo has been invited to be an NSERC chair member to help decontaminate massive tailings ponds in Canada.

    BioLargo sits on this chair along with Suncor, Syncrude, Shell, Canadian Natural Resources, Total, Epcor, Alberta Innovates, Alberta Environment and the University of Alberta.

    The AOS Filter is the biggest breakthrough in water treatment in history and will be showcased this August to major industry executives.

    The showcase will demonstrate the unprecedented results of the AOS Filter and the data the industry is looking for and will explode share prices.

    Walter Schindler just joined BioLargo as a key strategic advisor.

    When the story leaks out shares will explode. Shares are just starting to move and are a steal at anything under $1.00

    12 month price target $3
    24 month price target $12

    Sentiment: Strong Buy

  • BioLargo’s (BLGO) AOS filter has been repeatedly validated by researchers at the University of Alberta to decontaminate and disinfect water 100 times better, 10 times faster, and at 1/20th the cost of closest competing technology.

    BioLargo has been invited to be an NSERC chair member to help decontaminate massive tailings ponds in Canada.

    BioLargo sits on this chair along with Suncor, Syncrude, Shell, Canadian Natural Resources, Total, Epcor, Alberta Innovates, Alberta Environment and the University of Alberta.

    The AOS Filter is the biggest breakthrough in water treatment in history and will be showcased this August to major industry executives.

    The showcase will demonstrate the unprecedented results of the AOS Filter and the data the industry is looking for and will explode share prices.

    Walter Schindler just joined BioLargo as a key strategic advisor.

    When the story leaks out shares will explode. Shares are just starting to move up and are a steal at anything under $1.00

    12 month price target $3
    24 month price target $12

    Sentiment: Strong Buy

  • BioLargo’s AOS filter has been repeatedly validated by researchers at the University of Alberta to decontaminate and disinfect water 100 times better, 10 times faster, and at 1/20th the cost of closest competing technology.

    BioLargo has been invited to be an NSERC chair member to help decontaminate massive tailings ponds in Canada.

    BioLargo sits on this chair along with Suncor, Syncrude, Shell, Canadian Natural Resources, Total, Epcor, Alberta Innovates, Alberta Environment and the University of Alberta.

    The AOS Filter is the biggest breakthrough in water treatment in history and will be showcased this August to major industry executives.

    The showcase will demonstrate the unprecedented results of the AOS Filter and the data the industry is looking for and will explode share prices.

    Walter Schindler just joined BioLargo as a key strategic advisor.

    Shares are a steal at anything under $1.00

    12 month price target $3
    24 month price target $20

    Sentiment: Strong Buy

  • BioLargo (BLGO) and Lockheed (LMT) have proven and game changing technologies to help create abundant water for everyone.

    BioLargo’s breakthrough AOS Filter has been proven to decontaminate and disinfect water at unprecedented levels and speeds and cost 1/20th of the closest competing technology.

    The AOS Filter is showcasing this August at the University of Alberta to huge industry leaders and is extremely close to commercialization while Lockheed’s Graphene Filter is about 3 to 5 years away.

    To read report, copy and paste: Desalination Industry Screams for Cost Cutting Innovation: Lockheed And BioLargo Hold Key Technologies

    BioLargo is Strong Buy with $3.00 12-month Price Target and significantly higher in coming years.

    Sentiment: Strong Buy

  • BioLargo (BLGO) and Lockheed (LMT) have proven and game changing technologies to help create abundant water for everyone.

    BioLargo’s breakthrough AOS Filter has been proven to decontaminate and disinfect water at unprecedented levels and speeds and cost 1/20th of the closest competing technology.

    The AOS Filter is showcasing this August at the University of Alberta to huge industry leaders and is extremely close to commercialization while Lockheed’s Graphene Filter is about 3 to 5 years away.

    To read report, copy and paste: Desalination Industry Screams for Cost Cutting Innovation: Lockheed And BioLargo Hold Key Technologies

    BioLargo is Strong Buy with $3.00 12-month Price Target and significantly higher in coming years.

    Sentiment: Strong Buy

AMPE
2.68+0.08(+3.08%)Jul 31 4:02 PMEDT